A Study of CG-806 in Patients With Relapsed or Refractory CLL/SLL or Non-Hodgkin's Lymphomas

Clinical trial NCT03893682 · TERMINATED

Trial details

NCT number: NCT03893682
Sponsor: Aptose Biosciences Inc.
Status: TERMINATED
Phase: Phase 1
Study type: INTERVENTIONAL

Chronic Lymphocytic Leukemia Small Lymphocytic Lymphoma Non-Hodgkin's Lymphoma

Start date: 2019-04-30
Primary completion: 2024-05-17
Enrollment: 36

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.